ARS Pharmaceuticals Inc.
SPRY | NASDAQ
$4.35
+$0.24 (+5.84%)
At close: Sep 21, 2026, 4:00 PM ET
$4.35
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 116.93M | 98.99M | 84.28M | 142.77M | 112.34M | 97.12M | 89.15M | 2.57M | 500K | 10K | 30K | 30K | 219K | 673K | 1.32M | 2.07M | 2.41M | 4.06M | 5.51M | 4.75M | 4.22M | 2.11M |
Cost of Revenue | 30.53M | 22.66M | 20.42M | 21.11M | 13.03M | 14.95M | 16.13M | 15.65M | 18.54M | 18.85M | 20.07M | 20.22M | 21.01M | 18.15M | 17.12M | 17.48M | 18.81M | 20.08M | 20.27M | 16.82M | 11.7M | 6.49M |
Gross Profit | 86.4M | 76.32M | 63.86M | 121.66M | 99.31M | 82.18M | 73.02M | -13.08M | -18.04M | -18.84M | -20.04M | -20.19M | -20.79M | -17.48M | -15.8M | -15.41M | -16.4M | -16.02M | -14.77M | -12.07M | -7.48M | -4.37M |
Operating Income | -216.27M | -202.42M | -179.45M | -90.79M | -59.34M | -27.07M | -3.08M | -60.51M | -56.74M | -62M | -67.52M | -72.74M | -61.39M | -47.13M | -35.52M | -25.03M | -24.02M | -22.11M | -19.45M | -27.59M | -21.98M | -24M |
Interest Income | 3.57M | 1.97M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 47K | 47K | 47K | 47K | 16K | 16K | 16K |
Pretax Income | -215.51M | -198.06M | -171.38M | -79.75M | -47.73M | -15.36M | 8.29M | -49.1M | -44.84M | -49.7M | -54.37M | -61.63M | -53.34M | -42.39M | -34.68M | -25.39M | -24.62M | -22.85M | -20.24M | -28.19M | -22.38M | -24.2M |
Net Income | -215.43M | -197.98M | -171.3M | -80.04M | -48.02M | -15.65M | 8M | -49.1M | -44.84M | -49.7M | -54.37M | -61.63M | -53.34M | -42.39M | -34.68M | -25.39M | -24.62M | -22.85M | -20.24M | -28.19M | -22.38M | -24.2M |
Selling & General & Admin | 284.49M | 261.22M | 189.02M | 129.06M | 73.59M | 28.23M | 28.23M | 28.23M | 8.94M | 13.41M | 25.69M | 36.52M | 39.55M | 28.6M | 18.66M | 9.62M | 7.62M | 6.09M | 4.69M | 6.87M | 5.85M | 5.99M |
Research & Development | 15.23M | 14.57M | 13.18M | 12.77M | 14.44M | 17.3M | 19.58M | 19.96M | 18.54M | 18.95M | 20.27M | 21.57M | 22.46M | 19.51M | 18.38M | 17.58M | 18.81M | 20.08M | 20.27M | 25.01M | 19.89M | 19.25M |
Other Expenses | 2.95M | 2.95M | 41.1M | 70.62M | 70.62M | 63.72M | 28.29M | -754K | 11.22M | 10.81M | 1.53M | -5.54M | -21.41M | -18.45M | -17.32M | -17.58M | -18.81M | -20.08M | -20.27M | -16.36M | -11.24M | -5.62M |
Operating Expenses | 302.67M | 278.74M | 243.3M | 212.45M | 158.65M | 109.24M | 76.1M | 47.43M | 38.7M | 43.16M | 47.48M | 52.55M | 40.6M | 29.65M | 19.71M | 9.62M | 7.62M | 6.09M | 4.69M | 15.52M | 14.5M | 19.63M |
Interest Expense | 4.92M | 2.44M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 100K | 200K | 300K | 400K | 300K | 200K | 100K | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 333.19M | 301.4M | 263.73M | 233.56M | 171.68M | 124.19M | 92.23M | 63.07M | 57.24M | 62.01M | 67.55M | 72.77M | 61.61M | 47.8M | 36.83M | 27.1M | 26.43M | 26.17M | 24.96M | 32.35M | 26.2M | 26.11M |
Income Tax Expense | -80K | -80K | -80K | 288K | 288K | 288K | 288K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 99.31M | 99.3M | 98.57M | 98.81M | 98.36M | 98.06M | 97.95M | 97.03M | 96.83M | 96.49M | 96.13M | 95.58M | 94.91M | 94.23M | 94M | 93.77M | 93.77M | 93.77M | 35.04M | 35M | 34.88M | 34.77M |
Shares Outstanding (Diluted) | 99.31M | 99.3M | 98.57M | 98.81M | 98.36M | 98.06M | 97.95M | 97.03M | 96.83M | 96.49M | 96.13M | 95.58M | 94.91M | 94.23M | 94M | 93.77M | 93.77M | 93.77M | 35.04M | 35M | 34.88M | 34.77M |
EPS (Basic) | -2.18 | -2.01 | -1.75 | -0.82 | -0.50 | -0.17 | 0.07 | -0.51 | -0.47 | -0.52 | -0.57 | -0.65 | -0.56 | -0.45 | -0.37 | -0.37 | -0.47 | -0.53 | -0.58 | -0.81 | -0.64 | -0.70 |
EPS (Diluted) | -2.18 | -2.01 | -1.75 | -0.82 | -0.50 | -0.17 | 0.07 | -0.51 | -0.47 | -0.52 | -0.57 | -0.65 | -0.56 | -0.45 | -0.37 | -0.37 | -0.47 | -0.53 | -0.58 | -0.81 | -0.64 | -0.70 |
EBITDA | -209.03M | -192.17M | -168.05M | -76.81M | -47.12M | -15.01M | 8.37M | -49.04M | -44.78M | -49.63M | -54.29M | -61.31M | -53.04M | -42.1M | -34.36M | -25.12M | -24.35M | -22.59M | -19.82M | -27.51M | -21.7M | -23.12M |
EBIT | -212.2M | -195.62M | -171.38M | -79.75M | -47.73M | -15.36M | 8.29M | -49.1M | -44.84M | -49.7M | -54.37M | -61.63M | -53.34M | -42.39M | -34.68M | -25.39M | -24.62M | -22.85M | -20.04M | -27.98M | -22.17M | -23.99M |
Depreciation & Amortization | 3.17M | 3.45M | 3.33M | 2.94M | 609K | 348K | 79K | 62K | 62K | 64K | 73K | 316.5K | 302.5K | 289K | 319K | 271.5K | 266.5K | 261.5K | 213K | 470K | 468K | 869.5K |
Add to Watchlist
Select watchlists to add or remove SPRY